Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SNOA

Sonoma Pharmaceuticals (SNOA)

Sonoma Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNOA
DateTimeSourceHeadlineSymbolCompany
09/03/202408:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
09/03/202408:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNOASonoma Pharmaceuticals Inc
09/02/202408:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
10/01/202423:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
10/01/202408:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
30/12/202309:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
30/12/202309:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
30/12/202309:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
30/12/202309:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
30/12/202309:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
16/12/202309:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNOASonoma Pharmaceuticals Inc
21/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNOASonoma Pharmaceuticals Inc
14/11/202308:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
04/11/202307:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
30/10/202322:30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SNOASonoma Pharmaceuticals Inc
27/10/202315:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNOASonoma Pharmaceuticals Inc
14/10/202308:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
12/10/202307:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
11/10/202322:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
29/09/202306:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
21/09/202323:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:SNOASonoma Pharmaceuticals Inc
20/09/202306:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
11/08/202306:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
28/07/202306:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNOASonoma Pharmaceuticals Inc
22/07/202307:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
15/07/202307:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
04/07/202307:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
04/07/202307:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
22/06/202306:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
10/05/202321:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNOA